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ABSTRACT 
The human 60 kDa and microbial 65 kDa heat shock proteins (HSP) have been implicated in the pathogenesis of 
chronic periodontitis (CP) and coronary heart disease (CHD). We have studied 100 subjects: Group (a) consisted 
of patients with gingivitis (n = 25), group (b) were patients with CP (n = 25), group (c) patients with CHD and 
gingivitis (n = 25) and group (d) patients with CHD and CP (n = 25). PBMCs separated from peripheral blood 
were stimulated with medium, PMA/ionomycin, human HSP60, microbial HSP65, or no stimulus for 18 hours 
before intracellular IL-2, IFN-γ, TNF-α, IL-4, IL-5, or IL-17 were detected by flow cytometry. The mean fluo- 
rescence intensity (MFLI) for intracellular TNF-α was significantly increased when PBMC were stimulated with 
human HSP60 amongst the four groups (p = 0.001, ANOVA); pairwise comparisons revealed significant differ- 
ences in MFLI between the gingivitis group and the CP (p = 0.017); between gingivitis and ging/CHD (p = 0.001) 
as well; but no significant difference between the CP and CP/CHD (p = 0.442). There was no significant differ- 
ence in intracellular expression of IL-17, or any of the other cytokines tested; and the MFLI for HSP-stimulated 
were comparable to unstimulated cultures. When heat-labile human HSP60 was heated, intracellular cellular 
TNF-α expression was abrogated. In contrast, heat-stable LPS elicited TNF-α expression from monocytes in bulk 
cultures in all groups. These results suggest that the cytokine expression was dependent on human HSP60 and 
not LPS. Serum CRP was significantly associated with MFLI of intracellular TNF-α in CP patients (rs = 0.665, p 
= 0.026) and CP/CHD (rs = 0.699, p = 0.011). We conclude that human HSP60 elicits increased monocytic ex- 
pression of TNF-α in patients with CP, CP/CHD or ging/CHD compared to patients with gingivitis. Since the 
marker of inflammation, namely CRP correlates with CP with or without CHD and not with mild chronic gingi- 
vitis or ging/CHD, this suggests that human HSP60-induced production of TNF-α is associated with CP and not 
CHD. There was no significant difference in intracellular expression of IL-17. 
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1. Introduction 
Chronic periodontitis (CP) is an inflammatory disease 
characterised by connective tissue destruction and bone 
resorption, affecting 10% - 15% of the developed world 
population and is the major cause of tooth loss in adults 
[1]. There is evidence from cross-sectional studies im- 
plicating a multitude of organisms [2,3]. HSPs are highly 
conserved proteins [4,5], expressed in all eukaryotic and 
prokaryotic cells and involved in both innate and adap-  
tive immune responses, with innate responses helping to 
focus the cellular immune responses [6]. The high degree 
of homology between microbial and human HSPs has led 
to the hypothesis that tissue damage can occur as a result 
of cross-reactivity between bacterial and human HSPs. 
Humoral and T cell responses to HSP60/65 have been 
demonstrated in CP [4,5,7-9].  
In CP, there is controversy as to whether cells with a 
TH1 or TH2 cytokine profile are associated with disease 
progression, as both TH1 and TH2 cytokines are pro- 
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duced [10]. TH1 cells produce IL-2 and IFN-γ and facili-  
tate cell mediated immune responses and are pro-inflam- 
matory. In contrast, TH2 cells produce IL-4, IL-5 and 
IL-10 [11] simultaneously inhibiting TH1 responses and 
promoting humoral immunity. The histological picture of 
stable periodontitis lesions resembles a type IV delayed 
hypersensitivity response and in progressive lesions 
changes to lesions dominated by B cells and plasma cells 
[12]. These findings have been previously interpreted as 
meaning the stable lesion is mediated by TH1 cells and 
the progressive lesion by TH2 cells [12]. Animal studies 
suggest that Th1 are involved in the progression of chro- 
nic periodontitis [13-16]. However, several studies using 
human cells have reported a predominance of TH2 re- 
sponses in patients with CP compared to control patients 
[17-19]. These conflicting results may be due in part to 
differences in materials examined and methodology used.  
There is an association between CP and atherosclerosis 
(cardiovascular disease) and an increased risk of deve- 
loping cardiovascular disease in patients who have CP 
[20]. TH1 cytokines are found to be predominantly in- 
volved in the pathogenesis of atherosclerosis [21,22]. 
The TH1 subpopulation of CD4 + T cells predominates 
among atheroma plaque infiltrating lymphocytes [21,22] 
and becomes activated to secrete IFN-γ, IL-2, TNF-α, 
TNF-β [21-23], and IL-18 [23,24]. Upregulation of IFN- 
γ, IL-2, TNF-α, and TNF-β results in the activation of 
macrophages and vascular cells, promoting inflammation 
and cellular immunity [25]. IL-18 and its receptor act in 
concert to induce the production of IFN-γ, by smooth 
muscle cells [23]. Most human atherosclerotic lesions 
produce little TH2 type cytokines such as IL-4, IL-5 and 
IL-10 [21,22], except for IL-6 [26]. Furthermore, IL-6 
correlates with CRP and plaque size in patients with 
acute myocardial infarction [27].  
Various studies have demonstrated that HSP60/65 can 
activate monocytes/macrophages to produce pro-inflam- 
matory cytokines such as TNF-α [28-31], IL-6 [32,33] 
and IL-8 [32]. In addition, human HSP60 has been shown 
to induce PBMC to produce IL-4, IL-10 [34] and IFN-γ 
[19,34] in patients with rheumatoid arthritis and chronic 
periodontitis [35]. 
Cytokines produced by T-cells cannot always be easily 
categorised as either TH1 or TH2. TH17 cells, which 
produce IL-17 and have been implicated in autoimmune 
and chronic inflammatory conditions such as rheumatoid 
arthritis, may offer an alternative to the TH1/TH2 para- 
digm, however, their role in atherosclerosis is similarly 
unclear [36]. We have previously found autoimmune or 
cross-reactive CD4+ class II-restricted T cell responses 
to the human HSP60 in CP and CHD [8]. Given the po-
tential for innate immunity to focus adaptive immune 
responses, the objective of this study was to investigate 
the role of HSP-mediated induction of intracellular TNF- 
α, IFN-γ, and IL-2, IL-4 and IL-5, and IL-17 from PBMC 
of patients with chronic periodontitis and coronary heart 
disease, and to determine if these responses are related to 
inflammation, as reflected by CRP levels. 
2. Material and Methods 
2.1. Subjects 
Patients with CG and CP were recruited from the Unit of 
Periodontology at Guy’s and St Thomas’ Foundation 
Trust and the Coronary Care Unit at St Thomas’ Hospital 
(Table 1). All subjects were aged between 38 and 58 
years of age and had at least 15 standing teeth. Subjects 
were excluded from the study if they had systemic dis-
ease including diabetes mellitus, recurrent aphthous sto-
matitis, autoimmune disease, a history of malignancies, 
previous treatment for periodontitis, or a history of anti-
biotic therapy within the past six months prior to re-
cruitment. Subjects were allocated into 4 groups: gin- 
givitis, CP, Ging/CHD or CP/CHD. In each subject, pro- 
bing depths and recession of all teeth were determined 
using a William’s probe. Recession was measured as the 
distance from the cemento-enamel junction to the gin- 
gival margin. Measurements were taken from 6 sites; 
probing attachment loss was then calculated as the sum 
of probing pocket depth and recession. Periodontitis was 
defined as probing attachment loss ≥4 mm in at least 4 
teeth and CG group as probing attachment loss <2 mm in 
all teeth. Ethical committee approval was obtained (code 
no 98/12/04) and subject consent obtained. 40 ml of 
venous blood were withdrawn from each subject.  
The gingivitis subjects had minimal gingival inflam- 
mation and bleeding on probing (percentage of bleeding 
sites, mean ± s.d., 1.8 ± 0.8), compared with the diseased 
groups, with bleeding sites in CP (48.9 ± 11.7), coronary 
heart disease with gingivitis (Ging/CHD; 1.9 ± 0.7) and 
CP/CHD (45.9 ± 8.7), All Ging/CHD patients had CHD 
as determined by greater than 60% diameter stenosis in at 
least two major epicardial coronary arteries, and conversely 
only eight of the healthy control subjects were confirmed 
to be free of CHD based on angiography, the remaining 
members of the group denying any chest pain symptoms. 
2.2. HSP 
Recombinant HSP65 derived from Mycobacterium bovis 
was prepared at the National Institute of Public Health 
and Environmental Protection, Bilthoven, the Nether- 
lands and used at a predetermined optimal concentration 
of 10 µg/ml. Human HSP60 was purchased from Stres- 
sgen (Victoria, Canada). The two HSPs were detoxified 
using Detoxi-gel columns (Pierce, Oxford, UK) and the 
endotoxin level was determined by Limulus Amoebocyte 
Lysate assay (Sigma-Aldrich, Poole, Dorset, UK). The 
concentration of endotoxin was < 0.007 U/µg or 7 pg en- 
dotoxin/µg for both HSPs. 
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Table 1. Demographic data of patients showing median, interquartile range, mean and standard error of mean (SEM) of age, 
smoking status, smoking pack years and probing attachment level. 
Group (Number of patients)  Gingivitis n = 25 CP n = 25 Gingivitis/CHD n = 25 CP/CHD n = 25 
Age (years) ANOVA 
p = 0.239 
Median (IQ range) 48.00 (44 - 58) 49.00 (43 - 53) 52.00 (48 - 56) 54.00 (50 - 55) 
Mean (SEM) 50.20 (1.8) 48.70 (1.7) 51.90 (1.3) 52.10 (1.0) 
Smoking status 
NS 13 7 7 4 
ES 7 13 13 15 
PS 5 5 5 6 
Smoking Pack years ANOVA 
# < 0.001 *0.016 
**0.004 ***0.097 
Median (IQ range) 0.00 (0 - 4) 3.50 (0 - 25.5) 7.50 (0 - 30) 22.50 (5.0 - 37.5) 
Mean (SEM) 2.40 (1.7) 15.00 (4.0) 15.30 (3.4) 22.30 (3.7) 
Probing attachment level 
(mm) 
Median (IQ range) 0.90 (0.8 - 1.0) 3.20 (2.8 - 4.2) 1.00 (0.8 - 1.2) 3.20 (2.4 - 4.8) 
Mean (SEM) 0.90 (0.05) 3.70 (0.26) 1.00 (0.06) 4.00 (0.4) 
#significant p value for between group analysis of variance by Kruskal-Wallis test. *p value for pairwise comparison by Bonferroni between gingivitis and 
chronic periodontitis group. **p value for pairwise comparison by Bonferroni between gingivitis and gingivitis/CHD group. ***p value for pairwise comparison 
by Bonferroni between chronic periodontitis and chronic periodontis/CHD group. NS = never smokers ES = ex-smokers PS = present smokers IQ range = 
interquartile range. 
 
2.3. Separation of PBMC 
Peripheral blood mononuclear cells (PBMC) were sepe- 
rated from defibrinated blood samples by density gra- 
dient centrifugation (Nycomed Pharma As, Oslo, Nor- 
way). Blood was diluted 1:1 with tissue culture medium 
(RPMI 1640, Sigma-aldrich, UK) containing penicillin 
100 µg/ml, streptomycin 100 U/ml (Gibco, Paisley, Scot- 
land, UK), 2 mM L-glutamine (Sigma-aldrich, Irvine 
UK) at room temperature. This mixture was then laye- 
red onto an equal volume of lymphoprep (Ficoll-Paque 
TM PLUS, Amersham Biosciences, Uppsala Sweden) in 
50 ml plastic tubes (Bibby Sterilin Staffordshire UK) and 
centrifuged at 600 g for 30 minutes at 20˚C. Mononuc- 
lear cells were removed from the interface, and washed 
twice by spinning at 200 g for 10 minutes. The serum 
was retained and diluted with medium containing peni-
cillin 100 µg/ml, streptomycin 100 U/ml (Gibco, Paisley, 
Scotland, UK), 2 mM L-glutamine (Sigma-aldrich, UK) 
to 10% and used in cell cultures. 
2.4. Detection of Intracellular Cytokines by Flow 
Cytometry 
PBMC from 100 patients were cultured (5 × 105 cells/ 
well) in 24 well flat bottomed plates (Corning 25,820). 
Cytokine secretion by PBMC was blocked by adding 
monensin 4 µg/ml (Sigma-aldrich, Irvine UK) and bre- 
feldin A 10 µg/ml (Sigma-aldrich, Irvine UK). PBMC 
were then activated with phorbol myristate acetate (PMA) 
10 ng/ml plus ionomycin 1 µg/ml (Sigma-aldrich, Irvine 
UK), human HSP60 10 µg/ml (NSP-540 Stressgen  
UK), microbial HSP 65 10 µg/ml (NSP581 stressgen 
UK) or medium alone and incubated at previously pre- 
determined optimal time of 18 hours (Figure 1) in a hu-
midified atmosphere (5% CO2 at 37˚C). To investigate 
the role of LPS contamination some of the patients 
PBMC were further incubated with heat treated LPS or 
HSP by boiling 100˚C for 30 minutes. After 18 hours of 
incubation, cells were transferred into 5 ml round-bottom 
tubes (Falcon 352,058). Cells were stained using CD4 
fluorescein isothiocyanate (FITC) 5 µl (BD Pharmingen, 
San Diego), CD14 and CD8 peridinin chlorophyll-pro- 
tein (PerCP) 5 µl (BD Pharmingen, San Diego), then in- 
cubated in the dark at room temperature for 30 minutes. 
Cells were then centrifuged at 500 g for 5 minutes and 
washed once in 2 mls of PBS/azide (×1 PBS, 0.5% BSA, 
0.1% sodium azide). Cells were fixed with 1 ml FACS 
lysing solution containing <50% Diethylene glycol and < 
15% formaldehyde (BD Pharmingen 349,202) diluted 
1:10 with PBS/azide and incubated at room temperature 
for 10 minutes. The cells were washed in PBS/azide cells 
and then permeabilised with 500 µl of FACS permea- 
bilising solution (BD pharmingen 340,973) containing 
0.02% saponin, diluted 1:10 with deionised water. Cells 
were incubated for 10 minutes at room temperature and 
then centrifuged at 500 g for 5 minutes, washed once and 
resuspended in PBS/azide. 
Cells were then stained for intracellular cytokines, us-
ing 1 µg/ml of the following monoclonal antibodies con-
jugated to phycoerythrin (PE): anti-human IL-2 phy- 
coerythrin (PE) conjugate (554,566 BD Pharmingen, San 
Diego), anti-human IL-4PE conjugate (554,516 BD Phar- 
mingen, San Diego), anti-human IL-6PE conjugate 
(554,545 BD Pharmingen, San Diego), anti-human IFN-γ 
PE conjugate (554,701 BD Pharmingen, San Diego), 
anti-humanTNF-α PE conjugate (554,513 BD Pharmin-  
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(a)                                    (b)                                         (c) 
 
(d)                                    (e)                                         (f) 
 
(g) 
Figure 1. (a)-(g): Histogram of flow cytometric intracellular cytokine expression in monocytes stained with PE-labelled anti- 
cytokine monoclonal in a patient with chronic periodontitis antibody showing events versus mean fluorescence intensity. (a) 
TNF-∝ expression following stimulation with LPS; (b) TNF-∝ expression following stimulation with microbial HSP65; (c) 
TNF-∝ expression following stimulation with Human HSP60; (d) TNF-∝ expression following heat treatment with LPS; (e) 
TNF-∝ expression following stimulation with heat treated microbial HSP65; (f) TNF-∝ expression following stimulation with 
heat treated human HSP60; (g) TNF-∝ expression following incubation with medium only. (a) LPS TNF-∝; (b) HSP65 
TNF-∝; (c) HSP60 TNF-∝; (d) LPS TNF-α following heat treatment; (e) Heat denatured microbial HSP65 TNF-∝; (f) Heat 
denatured human HSP60 TNF-∝; (g) Medium TNF-∝. 
 
gen, San Diego), anti-human IL-17PE conjugate (560,438 
BD Pharmingen) or CD64PE conjugate (Serotec Oxford). 
After 30 minutes cells were washed twice and resus-
pended in PBS/Azide. Samples were analysed in a Coul-
ter Epics FACS machine, at least 10,000 events were 
analysed. Results were expressed as the mean fluores-
cence intensity (MFLI).  
2.5. Statistical Method 
Data recorded on dental charts and data obtained from 
the different experiments were transcribed onto computer  
records and analysed using SPSS-11.0 for windows 
(2001). All continuous variables were examined to estab-
lish whether the data conformed to a normal distribution 
with the Lilliefors (Kolmogorov-Smirnov) test for nor-
mality. Skewness and kurtosis were also examined. 
Analysis revealed non-normal distribution for all varia- 
bles tested which were not amenable to log or square root 
transformation. Therefore the non-parametric Kruskal- 
Wallis ANOVA test was used to assess differences be-
tween the groups established. The significance level was 
set at p < 0.05. Post ANOVA pairwise comparisons be-  
Ev
en
ls
M1
0
32
100 101 102 103 104
FL2 LOG
A. HASAN  ET  AL. 
OPEN ACCESS                                                                                      JIBTVA 
5 
tween the gingivitis group, CP group, ging/CHD group 
and CP with CP/CHD group were carried out with Mann- 
Whitney U test, using the Bonferroni correction. Interre-
lations between two variables were tested using the 
Spearman ranked correlation coefficients (rs); when the p 
value was <0.05, correction for smoking pack years was 
carried out. Non-parametric data are displayed in tables 
as median (1st and 3rd quartile). Data were also dis-
played as mean ± standard error of mean (SEM) to faci-
litate comparison with previously reported findings in the 
literature. 
2.6. Detection of C-Reactive Protein by ELISA 
Pre-diluted standard (50 µL) and blank were added to a 
96-well plate pre-coated with anti-serum CRP IgG (Ka- 
lon Biological Ltd). Serum samples were diluted 1:1000 
with assay diluent (Kalon Biological Ltd.) and dispensed 
in duplicates to designated wells in CRP precoated plates. 
The plate was then incubated at room temperature for 60 
minutes. Plates were washed 4 times with wash buffer 
(Kalon Biological Ltd); 100 µL of CRP tracer (affinity 
purified sheep anti-CRP labelled with alkaline phospha- 
tase, Kalon Biological Ltd UK) were then dispensed to 
each well and incubated uncovered for 30 minutes at 
room temperature. Plates were washed again 4 times with 
washing buffer (Kalon Biological Ltd, UK). 
Substrate solution (100 µl of 4-nitrophenylphosphate 
in substrate buffer Kalon Biological Ltd.) was then dis- 
pensed to each well and incubated at room temperature 
for 30 minutes. The reaction was stopped with 100 µl of 
(120 g/L) sodium hydroxide. Optical densities were read 
at 405 nm with microplate reader (Anthos 2001, Anthos 
labtec instruments UK). A standard curve was construc- 
ted with standard points and curve fitted with four para-  
meter logistic curve fitting software. Test serum values 
were then read off the standard curve. 
3. Results 
3.1. Detection of Intracellular Cytokines 
Unstimulated cells incubated in medium showed rela- 
tively low mean fluorescence intensity (MFLI) (Figure 
2(g)) in all intracellular cytokines studied; no statistically 
significant difference was found amongst the 4 groups 
(ANOVA, p = 0.803, Table 2).  
There was a statistically significant difference amongst 
the 4 groups in MFLI for intracellular TNF-α by ANO- 
VA (p = 0.001) (Table 2, Figures 2 and 3); also between 
the gingivitis group compared to the CP group (p = 0.017) 
and between the gingivitis group and the ging/CHD  
 
 
Figure 2. Detection of intracellular TNF-α in monocytes 
stimulated with human HSP60 showing median, interquar-
tile range, mean and standard error of mean (SEM) of 
MFLI for each of 4 groups of patients (ANOVA p = 0.001) o 
maximum; × 75th percentile;  minimum;   25th percentile; 
     median. 
 
Table 2. Detection of intracellular TNF-α in monocytes stimulated with phorbol myristate acetate(PMA)/ionomycin, human 
HSP60, microbial HSP65 or no stimulus showing median, interquartile range, mean and standard error of mean (SEM) of 
MFLI. 
Intracellular TNF-α  Gingivitis (25) CP (25) Ging/CHD (25) CP/CHD (25) 
Medium ANOVA 
p = 0.061 
Median (IQ range) 3.06 (2.5 - 8.2) 4.82 (4.4 - 6.8) 8.10 (5.6 - 10.0) 4.21 (3.7 - 6.1) 
Mean (SEM) 6.70 (2.1) 7.40 (1.3) 8.80 (2.4) 5.30 (0.9) 
PMA/ionomycin 
ANOVA 
p = 0.803 
Median (IQ range) 40.40 (34.3 - 65.4) 58.60 (37.3 - 68.0) 56.50 (45.3 - 87.0) 49.40 (37.3 - 67.9) 
Mean (SEM) 68.30 (18.7) 55.60 (20.8) 78.20 (19.1) 57.00 (37.3 - 67.9) 
Human HSP60 ANOVA 
#p = 0.001 *0.017 
**0.001 ***0.442 
Median (IQ range) 10.20 (4.8 - 17.4) 20.40 (14.1 - 32.3) 36.40 (27.0 - 51.0) 24.30 (14.8 - 40.1) 
Mean (SEM) 12.30 (2.9) 24.20 (2.3) 38.90 (8.1) 28.70 (4.6) 
Microbial HSP65 ANOVA 
p = 0.329 
Median (IQ range) 9.040 (4.2 - 22.6) 14.00 (10.0 - 32.6) 22.50 (13.9 - 24.7) 16.50 (13.1 - 32.0) 
Mean (SEM) 13.10 (3.1) 22.00 (2.2) 21.20 (13.9-24.7) 23.20 (4.6) 
#significant p value for between group analysis of variance by Kruskal-Wallis test. *p value for pairwise comparison by Bonferroni between gingivitis and 
chronic periodontitis group. **p value for pairwise comparison by Bonferroni between gingivitis and gingivitis/CHD group. ***p value for pairwise comparison 
by Bonferroni between chronic periodontitis and chronic periodontis/CHD group. 
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group (p = 0.001) (Table 2). However, there was no statis-
tical difference between the MFLI for the CP group and 
the CP/CHD group (p = 0.442) (Table 2, Figures 2 and 3). 
There were no statistically significant differences 
amongst the groups in the MFLI for any of the remaining 
intracellular cytokines (IFN-γ, IL-2, IL-4, IL-5, IL-6, 
IL-17) following stimulation with human HSP60 or mi-
crobial HSP65. 
There were no significant differences in intracellular 
IFN-γ, IL-2, IL-4, or IL-6 amongst the 4 groups when 
monocytes were stimulated with either human HSP60 or 
microbial HSP65. 
3.2. CRP 
Serum CRP was significantly associated with MFLI of 
intracellular TNF-α in CP patients (rs = 0.665, p = 0.026) 
and CP/CHD (rs = 0.699, p = 0.011) even after correction 
for smoking pack years in chronic periodontitis (rs = 
0.649, p = 0.002) and chronic periodontitis/CHD (rs = 
0.603, p = 0.011) (Table 3). However, serum CRP levels 
were not significantly associated with MFLI of intra- 
cellular TNF-α production in the gingivitis group (rs = 
0.596, p = 0.053) and the gingivitis/CHD group (rs = 
0.515, p = 0.128). There was no direct association be- 
 
 
Figure 3. Detection of intracellular TNF-α in monocytes fol- 
lowing stimulation with microbial HSP65 in 4 groups of 
patients (ANOVA p = 0.329). 
 
Table 3. Association of serum CRP and smoking pack years 
to human HSP60-induced monocytic production of intra-
cellular TNF-α in 4 groups of patients. 
Intracellular TNF-α CRP Smoking pack years 
Group rs p value rs p value 
Gingivitis n = 25 0.596 0.053 0.253 0.452 
CP n = 25 #0.665 *0.026 0.296 0.377 
Ging/CHD n = 25 0.515 0.128 0.325 0.359 
CP/CHD n = 25 #0.699 *0.011 0.526 0.079 
Correlation coefficient between CRP and TNF-α in the chronic periodontitis 
(r = 0.649, p = 0.002) and chronic periodontitis/CHD (rs = 0.603, p = 0.011) 
group remained significant even after correction for smoking pack years. rs 
= Spearman rank correlation coefficient; p = probability value; #moderate 
correlation coefficient; *significant p value. 
tween smoking pack years to human HSP60 induced in- 
tracellular TNF-α production in the control (rs = 0.253, p 
= 0.452), CP (rs = 0.296, p = 0.377), ging/CHD (rs = 
0.325, p = 0.359) and CP/CHD (rs = 0.526, p = 0.079) 
(Table 3). 
3.3. Excluding Any Activity Due to 
Contamination of HSP with LPS 
To exclude the possibility of LPS contamination affec- 
ting the production of intracellular cytokine, the micro- 
bial HSP65 and human HSP60 was heat-treated as pre- 
viously described [8]. HSP is heat labile whereas, LPS is 
heat stable [8]. Stimulation of cultures with heat-treated 
microbial HSP65 (Figure 1(e)) and human HSP60 (Fig- 
ure 1(f)) abolished the production of intracellular TNF-α. 
However, LPS stimulation of PBMC producing TNF-α 
(Figure 1(a)) was not affected by heat treatment (Figure 
1(d)). The abrogation of TNF-α production makes it un-
likely that LPS contamination was responsible for the 
intracellular cytokine expression. 
4. Discussion 
Unstimulated cells incubated in medium showed rela- 
tively low mean fluorescence intensity (Table 2). This is 
not surprising as unstimulated cells usually produce little 
or no measurable cytokines [37] except in patients with 
progressive malignancies [38]. PMA/ionomycin stimula- 
tion of cells resulted in an increase in the mean fluores- 
cence intensity of TH1 cytokines in both controls and 
patients with CP and CHD (Table 2). Although this in- 
creased mean fluorescence intensity was not statistically 
significant, there was a trend towards higher mean fluo- 
rescence intensities for TNF-α and IFN-γ in the patient 
groups compared to the control group (Table 2). There 
was little or no increase in the mean fluorescence in- 
tensity for IL-4 and IL-5 following stimulation with 
PMA/ionomycin in the patient groups. Perhaps the sti- 
mulation protocol employed in this study was not sen- 
sitive enough to detect IL-4 and IL-5 [39]; as PMA/iono- 
mycin stimulation of IL-4 and IL-10 was insufficient for 
their intracellular detection, often requiring secondary 
culture with cytokines followed by re-stimulation with 
mitogen [40]. However, some studies have shown an 
induction of intracellular IL-4 with only primary stimula- 
tion with PMA/ionomycin [38].  
Stimulation of cell cultures with human HSP60 [38,41] 
resulted in a statistically significant increase in mean 
fluorescence intensity for intracellular TNF-α in the CP 
and CHD patients compared with gingivitis group (Table 
2, Figure 2), but no significant differences were seen 
amongst the 4 groups for intracellular IFN-γ, IL-2, IL-4 
IL-5 and IL-17. In order to ensure HSP60 and not LPS 
was eliciting the cytokine response, we denatured HSP60 
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before addition to the culture. Denaturing HSP comple- 
tely abolished the cytokine response (Figure 1(f)). Since 
LPS is heat stable, this suggests that HSP is eliciting the 
cytokine production, and not LPS. Either CD14 or TLR4 
or both receptors have been implicated in HSP recog- 
nition and are thought to mediate activation of monocy- 
tes/macrophages in response to human HSP60-stimula- 
tion [6,42]. As HSP60 has been implicated in the patho- 
genesis of chronic inflammatory diseases such as rheu- 
matoid arthritis [43] and atherosclerosis [44], the abun- 
dant expression of HSP and TLR-4 within periodontitis 
lesions [42,45] together with HSP’s role in eliciting 
TNF-α production , suggests that HSP60 is also likely to 
be playing a role in chronic inflammatory periodontal 
disease. The highest intracellular TNF-α levels were in 
patients with CHD with or without periodontal disease 
and CP, suggesting that the cytokine levels are related to 
disease severity, however, the smoking status was not the 
same across the groups potentially confounding the re-
sults.  
Although microbial HSP65 cultures showed an in- 
crease in mean fluorescence intensity for intracellular 
TNF-α compared to unstimulated samples, there was no 
statistically significant difference amongst the 4 groups 
(Table 2, Figure 2). Additionally, no significant diffe- 
rences were seen amongst the groups in the mean fluo- 
rescence intensity of intracellular IFN-α, IL-2, IL-4 and 
IL-5 (data not shown). 
These results are consistent with previous studies 
showing that TNF-α can be induced by HSP60 in mono- 
cyte/macrophages [28-30]. The lack of any significant 
difference in the mean fluorescence intensity of intra- 
cellular TNF-α amongst groups with periodontal disease 
with/without coronary artery disease following stimula- 
tion with microbial HSP65 is consistent with the lympho- 
proliferative responses which showed no difference be- 
tween the 4 groups. Most subjects respond to microbial 
HSP65 and this may be a result of the ability of microbial 
HSP65 to stimulate both naïve and primed cells [8,31, 
46]. 
Smoking has been a confounding variable in studies of 
the association of CP and CHD [47]. Exposure to smo- 
king has been associated with reduced release of TNF-α 
in human alveolar macrophages [48,49]. In this study 
there was significant difference in the smoking pack 
years amongst the patient group compared to the gingivi- 
tis group (Table 2). There was no correlation of smoking 
pack years to human HSP60-induced intracellular TNF-α 
production in this study (Table 2).  
CRP a marker of inflammation was significantly asso- 
ciated with human HSP 60 induced intracellular TNF-α 
production in the CP group with or without CHD, but not 
in the gingivitis group or the ging/CHD (Table 2). The 
lack of significant association between serum CRP and 
TNF-α in the gingivitis and ging/CHD groups may 
simply reflect the complexity of inflammation and its 
many pathways and HSP60-induced TNF-α may be an 
indirect association with CRP and that CP induced in- 
flammation drives TNF-α production. There is evidence 
for this from previous studies showing that CRP and 
TNF-α are both increased in patients with CP [48-50] 
and reduced following anti-microbial and non-surgical 
treatment of chronic periodontitis [50]. 
5. Conclusion 
This study suggests that human HSP60 but not microbial 
HSP65 induces significant production of intracellular 
TNF-α in patients with CP and CHD. Since the marker 
of inflammation, namely CRP correlates with CP with or 
without CHD and not with mild chronic gingivitis or 
ging/CHD, this suggests that human HSP60-induced pro- 
duction of TNF-α is associated with CP and not CHD. 
There was no direct link between smoking pack years 
and the production of human HSP60 induction of TNF-α, 
however this merits further investigation. 
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